REVANCE THERAPEUTICS
Revance Therapeutics is a biopharmaceutical company, engages in developing and commercializing products and treatments in dermatology and aesthetic medicines. Its products include RT001, a physician-applied topical botulinum toxin type A (BoNT-A) for cosmetic, hyperhidrosis, and dermatologic indications. The company was formerly known as Essentia Biosystems, Inc. Revance Therapeutics, Inc. was founded in 2002 and is based in Mountain View, California.
REVANCE THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2002-01-01
Address:
Newark, California, United States
Country:
United States
Website Url:
http://www.revance.com
Total Employee:
101+
Status:
Active
Contact:
+1 510 742 3400
Email Addresses:
[email protected]
Total Funding:
1.49 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins
Similar Organizations
1717 Life Science Ventures
1717 Life Science Ventures develops precision radiopharmaceuticals for the diagnosis and treatment of malignant oncological diseases.
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Lucy Therapeutics
Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Proventiv Therapeutics
Proventiv Therapeutics develops and commercializes pharmaceutical products to treat and prevent the clinical consequences of diseases.
Secant Therapeutics
Secant Therapeutics develops a percutaneous transcatheter direct plication annuloplasty (DPA) device.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-05-19 | HintMD | HintMD acquired by Revance Therapeutics | N/A |
Investors List
Athyrium Capital Management LP
Athyrium Capital Management LP investment in Post-IPO Debt - Revance Therapeutics
Delphi Ventures
Delphi Ventures investment in Series E - Revance Therapeutics
NovaQuest
NovaQuest investment in Series E - Revance Therapeutics
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Series E - Revance Therapeutics
Shepherd Ventures
Shepherd Ventures investment in Series D - Revance Therapeutics
CNF Investments, LLC
CNF Investments, LLC investment in Series D - Revance Therapeutics
Vivo Capital
Vivo Capital investment in Series D - Revance Therapeutics
Novaquest Capital Management
Novaquest Capital Management investment in Series D - Revance Therapeutics
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Series D - Revance Therapeutics
Palo Alto Investors
Palo Alto Investors investment in Series D - Revance Therapeutics
Official Site Inspections
http://www.revance.com Semrush global rank: 1.91 M Semrush visits lastest month: 11.4 K
- Host name: 139.52.194.35.bc.googleusercontent.com
- IP address: 35.194.52.139
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Revance Therapeutics"
Home - Revance
Nov 7, 2024 · Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, as well as financial technology services for aesthetic practices.See details»
Official Site: Revance Aesthetics
Providing a new level of excellence in training, education, marketing, practice development, and more. Revance Aesthetics is meeting unmet market needs with cutting-edge innovation and first-of-its kind products. Our journey is as unique …See details»
Leadership Team - Revance
Revance’s leadership is committed to setting the new standard in healthcare and has deep experience commercializing products in highly competitive markets. As a group, we represent …See details»
Board of Directors - Revance
Our Board brings together exceptional executives in science, healthcare, and business who dare to make a difference.See details»
Revance Therapeutics, Inc. - Investor Relations
Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences.See details»
Revance Therapeutics - Crunchbase Company Profile
Revance Therapeutics is a biopharmaceutical company, engages in developing and commercializing products and treatments in dermatology and aesthetic medicines. Its products include RT001, a physician-applied topical botulinum …See details»
Revance Therapeutics, Inc. - Crown Laboratories and Revance …
Aug 12, 2024 · Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that enhance patient outcomes and physician …See details»
2022 Environmental, Social and Governance Report
Revance (Nasdaq: RVNC) is a biotechnology company committed to setting the new standard in aesthetics and therapeutics with innovative products and services that elevate patient and …See details»
Revance Provides Corporate Update, Preliminary Fourth Quarter …
Jan 8, 2024 · – Provides 2024 product revenue guidance of at least $280 million, supporting blockbuster potential in U.S. aesthetics. – 2024 GAAP and non-GAAP operating expense …See details»
Revance is being bought up by Crown Laboratories for …
Aug 12, 2024 · Revance and Crown—a privately held skin care company with multiple marketed products of its own—are merging, the companies said in a release Monday.See details»
Sustainability - Revance
At Revance, our mission is to achieve the highest levels of excellence in all we do, by living our values–speed, authenticity, audacity, grit and empathy–as we set the new standard in healthcare. These values shape every aspect of our …See details»
Botox rival Revance to go private in $924 million deal | Reuters
Aug 12, 2024 · Anti-wrinkle injection maker Revance Therapeutics has agreed to be bought by privately held Crown Laboratories in a deal valued at $924 million, including debt, seeking …See details»
Revance Therapeutics, Inc. - Revance Provides Corporate Update …
Jan 7, 2021 · NASHVILLE, Tenn. -- (BUSINESS WIRE)--Jan. 7, 2021-- Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and …See details»
Crown Laboratories x Revance to Merge, Forming Skin Care
Aug 13, 2024 · Crown Laboratories, Inc. and Revance Therapeutics, Inc. are set to merge into a single enterprise valued $924 million. The move unites skin care and aesthetics expertise, …See details»
Working at Revance - Great Place To Work®
Why Work at Revance? See what employees say about what makes Revance a great workplace. These words are drawn from employee comments on the Trust Indexâ„¢ survey.See details»
Crown Laboratories and Revance Announce Entry Into Merger …
Aug 12, 2024 · Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that enhance patient outcomes and physician …See details»
Revance Company Profile, Stock Price, News, Rankings - Fortune
Best Small and Medium Workplaces in Biotechnology and Pharmaceuticals 2023 Employees say: "Revance is an incredible place to work. I feel very supported and proud to work here.See details»
Revance Provides Corporate Update and Anticipated Milestones …
Jan 7, 2021 · NASHVILLE, Tenn.-- ( BUSINESS WIRE )--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, …See details»
Revance Reports Fourth Quarter and Full Year 2023 Financial …
Feb 28, 2024 · – Q4 and full year 2023 product revenue (DAXXIFY® and RHA® Collection) of $58.5 million and $212.7 million, representing approximately 28% and 80% YoY growth, …See details»
Revance Therapeutics (RVNC-Q) Stock Price and News
Revance is a Silicon Valley-based biotechnology company. The company is developing a portfolio of products for aesthetic medicine and underserved therapeutic specialties, including...See details»